Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation
- PMID: 9819295
- DOI: 10.1016/s0091-6749(98)70018-1
Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation
Abstract
Background: Bronchial asthma is characterized by airway structural changes, including mucosal inflammation and subepithelial collagen deposition. An imbalance between the matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) is thought to play a critical role in the synthesis or degradation of the extracellular matrix of the airway architecture. However, the relationship between subepithelial basement membrane thickness and these enzymes in asthma has not been determined.
Objective: We compared the thickness of collagen and tenascin deposition and the expression of MMP-9 and TIMP-1 in bronchial biopsy specimens from subjects with asthma and control subjects.
Methods: Bronchial biopsy specimens were obtained from 25 subjects with asthma and 10 healthy control subjects to estimate the extent of collagen and tenascin deposition in subepithelial reticular basement membrane by immunohistochemical staining. Using a computer-assisted image analysis system, we quantitated expression of both epithelial and submucosal MMP-9 and TIMP-1. The numbers of inflammatory cells were also determined.
Results: Subjects with asthma exhibited greater thickness of collagen III (P <.01), collagen V (P <.01), and tenascin (P <.01) deposition in reticular basement membrane than did control subjects. The proportions of epithelium and submucosa immunoreactive to MMP-9 and TIMP-1 were significantly higher in the subjects with asthma than in the control subjects (each P <.001). Submucosal expression of MMP-9 was significantly higher than that of TIMP-1 in subjects with asthma (P <.01). Significant correlations were found between the number of myofibroblasts and thicknesses of collagen III (rs = 0. 70, P <.001), collagen V (rs = 0.67, P <.001), and tenascin (rs = 0. 58, P <.01) in subjects with asthma. On the other hand, the number of eosinophils was correlated with degree of mucosal expression of MMP-9 (rs = 0.43, P <.05) and TIMP-1 (rs = 0.69, P <.001). In subjects with asthma, a significant inverse correlation was found between subepithelial fibrosis and FEV1 (type III collagen, rs = -0. 89, P <.001; type V collagen, rs = -0.90, P <.001; tenascin, rs = -0. 88, P <.001), and airway responsiveness (type III collagen, rs = -0. 59, P <.01; type V collagen, rs = -0.47, P <.05; tenascin, rs = -0. 48, P <.05).
Conclusion: These findings suggest that collagen III, collagen V, and tenascin deposition in basement membrane in subjects with bronchial asthma are associated with increased expression of MMP-9, which may be produced by eosinophils, and that airway remodeling in subjects with asthma may be related to air-flow obstruction and airway hyperresponsiveness.
Similar articles
-
Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma.J Allergy Clin Immunol. 1999 Aug;104(2 Pt 1):356-63. doi: 10.1016/s0091-6749(99)70379-9. J Allergy Clin Immunol. 1999. PMID: 10452757 Clinical Trial.
-
Expression of growth factors and remodelling of the airway wall in bronchial asthma.Thorax. 1998 Jan;53(1):21-7. doi: 10.1136/thx.53.1.21. Thorax. 1998. PMID: 9577517 Free PMC article.
-
Bronchial responsiveness to distilled water and methacholine and its relationship to inflammation and remodeling of the airways in asthma.Am J Respir Crit Care Med. 1996 Mar;153(3):910-7. doi: 10.1164/ajrccm.153.3.8630572. Am J Respir Crit Care Med. 1996. PMID: 8630572
-
[Implication of extracellular matrix metalloproteinases in the course of chronic inflammatory airway diseases].Morphologie. 2000 Jun;84(265):45-9. Morphologie. 2000. PMID: 11048298 Review. French.
-
Role of human airway smooth muscle in altered extracellular matrix production in asthma.Clin Exp Pharmacol Physiol. 2001 Mar;28(3):233-6. doi: 10.1046/j.1440-1681.2001.03426.x. Clin Exp Pharmacol Physiol. 2001. PMID: 11236132 Review.
Cited by
-
Cytokines in asthma.Thorax. 1999 Sep;54(9):825-57. doi: 10.1136/thx.54.9.825. Thorax. 1999. PMID: 10456976 Free PMC article. Review. No abstract available.
-
Induction of the plasminogen activator system by mechanical stimulation of human bronchial epithelial cells.Am J Respir Cell Mol Biol. 2006 Dec;35(6):628-38. doi: 10.1165/rcmb.2006-0040OC. Epub 2006 Jun 22. Am J Respir Cell Mol Biol. 2006. PMID: 16794260 Free PMC article.
-
Tissue inhibitor of metalloproteinase-1 modulates allergic lung inflammation in murine asthma.Clin Immunol. 2009 Feb;130(2):186-98. doi: 10.1016/j.clim.2008.08.029. Epub 2008 Oct 26. Clin Immunol. 2009. PMID: 18955015 Free PMC article.
-
Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13-induced inflammation and remodeling.J Clin Invest. 2002 Aug;110(4):463-74. doi: 10.1172/JCI14136. J Clin Invest. 2002. PMID: 12189240 Free PMC article.
-
Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics.J Clin Invest. 2003 Oct;112(7):1029-36. doi: 10.1172/JCI17974. J Clin Invest. 2003. PMID: 14523040 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous